Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-09 Sale | 2024-07-09 5:15 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 453,960 | $38.21 | $17,346,919 | 723,246 (Indirect) | View |
| 2024-06-12 Sale | 2024-06-14 6:01 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 26,940 | $35.27 | $950,174 | 802,022 (Indirect) | View |
| 2024-03-14 Sale | 2024-03-15 7:23 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 127,543 | $40.25 | $5,133,263 | 806,697 (Indirect) | View |
| 2024-03-11 Sale | 2024-03-13 7:52 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 353,357 | $42.2 | $14,912,376 | 828,830 (Indirect) | View |
| 2023-01-11 Sale | 2023-01-13 4:53 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 126,474 | $30.22 | $3,821,739 | 890,148 (Indirect) | View |
| 2022-12-14 Sale | 2022-12-16 5:05 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 382,244 | $31.36 | $11,985,954 | 917,811 (Indirect) | View |
| 2022-11-02 Sale | 2022-11-04 4:31 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 220,016 | $30.01 | $6,602,952 | 1,001,417 (Indirect) | View |
| 2022-10-28 Sale | 2022-11-01 7:36 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 288,702 | $30.26 | $8,735,143 | 1,049,540 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-11 9:11 pm | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 535,000 | $14 | $7,490,000 | 4,808,896 (Indirect) | View |
| 2021-08-11 Sale | 2021-08-12 10:43 am | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 242,133 | $61 | $14,770,113 | 6,875,698 (Indirect) | View |
| 2021-03-12 Sale | 2021-03-16 7:39 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 229,350 | $56.5 | $12,958,275 | 7,998,317 (Indirect) | View |
| 2020-06-29 Purchase | 2020-07-01 4:48 pm | Magenta Therapeutics Inc. | MGTA | Booth Bruce Director | 1,250,000 | $8 | $10,000,000 | 5,367,125 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:05 pm | N/A 2034-06-05 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 18,068 | $0 | 18,068 (Direct) | View |
| 2024-05-03 Option Award | 2024-05-07 5:00 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 43,373 | $0 | 43,373 (Direct) | View |
| 2024-05-03 Disposition | 2024-05-07 5:00 pm | N/A 2032-06-09 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 26,083 | $0 | 43,373 (Direct) | View |
| 2024-05-03 Disposition | 2024-05-07 5:00 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 9,713 | $7.618 | 43,373 (Direct) | View |
| 2024-05-03 Disposition | 2024-05-07 5:00 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 7,577 | $9.63 | 43,373 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 6:57 pm | N/A 2034-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 34,612 | $0 | 34,612 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:06 pm | N/A 2033-06-07 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 13,928 | $0 | 5,850,802 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:27 pm | N/A 2033-06-05 | AVROBIO Inc. | AVRO | Booth Bruce Director | 17,643 | $0 | 17,643 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:12 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 9,713 | $7.618 | 9,713 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 7:28 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | Booth Bruce Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:05 pm | N/A 2032-06-14 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-09 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 12,155 | $0 | 5,849,029 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:36 pm | N/A 2032-06-07 | AVROBIO Inc. | AVRO | Booth Bruce Director | 34,956 | $0 | 34,956 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:05 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 7,577 | $9.63 | 7,577 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-11 9:11 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 14,562,661 | $0 | 4,808,896 (Indirect) | View |
Ownership | 2022-01-06 8:30 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 0 | $0 | 5,301,874 (Indirect) | View |
| 2021-06-16 Option Award | 2021-06-17 4:47 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 20,063 | $0 | 20,063 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:32 pm | N/A 2031-06-09 | AVROBIO Inc. | AVRO | Booth Bruce Director | 17,438 | $0 | 17,438 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 6:35 pm | N/A 2031-05-31 | Magenta Therapeutics Inc. | MGTA | Booth Bruce Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 21,561,726 | $0 | 1,112,686 (Indirect) | View |
| 2020-08-20 Option Award | 2020-08-21 6:31 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 40,127 | $0 | 40,127 (Direct) | View |
Ownership | 2020-08-20 8:38 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 0 | $0 | 9,061,668 (Indirect) | View |
| 2020-07-01 Option Award | 2020-07-06 4:52 pm | N/A 2030-07-01 | Unum Therapeutics Inc. | UMRX | Booth Bruce Director | 61,338 | $0.3118 | 61,338 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:23 pm | N/A 2030-06-09 | Unum Therapeutics Inc. | UMRX | Booth Bruce Director | 14,331 | $0 | 14,331 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:25 pm | N/A 2030-06-04 | Magenta Therapeutics Inc. | MGTA | Booth Bruce Director | 18,188 | $0 | 18,188 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-05 5:18 pm | N/A 2030-06-03 | AVROBIO Inc. | AVRO | Booth Bruce Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2020-04-06 Option Award | 2020-04-08 5:40 pm | N/A 2030-04-06 | Unum Therapeutics Inc. | UMRX | Booth Bruce Director | 86,735 | $0.2205 | 86,735 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 4:45 pm | N/A 2030-01-02 | Unum Therapeutics Inc. | UMRX | Booth Bruce Director | 39,996 | $0.4532 | 39,996 (Direct) | View |